ABIOMED, INC.

Manufacturer adverse-event records for ABIOMED, INC. come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 1996–2026 · heavy-book · elevated Death-code · balanced

Death-code intensity

ABIOMED, INC. carries an elevated Death-code share

Death-coded event_type rows are 4,175 of 34,504 (12.10% · elevated tercile among 443 manufacturers). Absolute volume is heavy-book.

What the Death-code reading shows for ABIOMED, INC.

The standout signal for ABIOMED, INC. is Death-code intensity: 12.10% of 34,504 reports (elevated tercile), while absolute volume is heavy-book.

As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair ABIOMED, INC. with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.

Reports span 18 device types, led in this extract by Injury at 16,623 (48.2% of event_type total). Peak single-year volume reaches 18,454 reports across 31 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

34,504
Total Reports
4,175
Event-type Death
16,623
Injury Reports
18
Device Types

Event Types

Injury 16,623 (48.2%)
Malfunction 13,700 (39.7%)
Death 4,175 (12.1%)
3 (0.0%)
Other 3 (0.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Required Intervention 16,070 (42.0%)
13,532 (35.4%)
Death 2,990 (7.8%)
R 1,613 (4.2%)
D 1,294 (3.4%)
Other 958 (2.5%)
L 665 (1.7%)
Life Threatening 622 (1.6%)
O 251 (0.7%)
S 121 (0.3%)
Disability 87 (0.2%)
Hospitalization 42 (0.1%)
H 31 (0.1%)

Yearly Trend

96
1996: 22
97
1997: 42
98
1998: 34
99
1999: 37
00
2000: 23
01
2001: 30
02
2002: 1
03
2003: 4
04
2004: 12
05
2005: 6
06
2006: 3
07
2007: 9
08
2008: 7
09
2009: 3
10
2010: 6
11
2011: 4
12
2012: 5
13
2013: 2
14
2014: 5
15
2015: 2
16
2016: 13
17
2017: 35
18
2018: 68
19
2019: 168
20
2020: 250
21
2021: 431
22
2022: 306
23
2023: 3,575
24
2024: 18,454
25
2025: 10,057
26
2026: 890